Corvus Pharmaceuticals is a clinical and late-stage biopharmaceutical company developing novel therapies with the potential to significantly improve the treatment of immune diseases and cancer. Our lead program, soquelitinib, is a first-in-class, oral therapy that selectively inhibits ITK to modulate and control parallel signaling pathways in the immune system. We are a small innovative and collaborative biotech company looking for like minded individuals to help grow the company and career. We work on-site alongside our colleagues to help build collaboration.
ROLE AND RESPONSIBILITIES
Powered by JazzHR